5:35 PM ET
Form 4
Insider Selling
Crispr Therapeutics CEO Samarth Kulkarni Sells $2.38M of Stock
Samarth Kulkarni, CEO, sold 47,837 shares of Crispr Therapeutics AG at $49.78 a share, worth $2.38M in total on Oct 19, 2026. Shares held after the trade: 311,899 (-13.3%).
- Value
- $2.38M
- Shares
- 47,837
- Price
- $49.78
- Role
- CEO
- Holding change
- -13.3%
- Trade date
- Oct 19, 2026